Biodesix, Inc.
USD23.12
-0.69 (-2.91%)
CEO
Scott Hutton
IPO Date
2020-10-28
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$23.70
Prev. Close
$23.81
Day Low
$21.58
Day High
$24.22
52W Low
$5.26
52W High
$24.34
Market Cap
$0.19B
Volume
0.07M
| -4.6 |
| 31 Dec 2023 | FY | 73.5% | -106.2% | -1138.6% | -52.6% | 13.25 | 1.19 | -2.9 |
| 31 Dec 2022 | FY | 63.0% | -171.3% | -317.6% | -70.4% | 1.55 | 2.34 | -1.5 |
| 31 Dec 2021 | FY | 44.0% | -79.2% | -218.8% | -56.7% | 0.51 | 1.51 | -3.4 |
| 31 Dec 2020 | FY | 51.7% | -68.8% | -76.2% | -25.9% | 0.67 | 2.68 | -62.2 |
| 31 Dec 2019 | FY | 75.3% | -125.1% | 13.4% | -73.8% | -0.16 | 0.56 | -381.2 |
| 31 Dec 2018 | FY | 78.4% | -128.1% | 13.2% | -67.0% | -0.12 | 2.22 | -13.0 |
| -3.4 |
| 30 Sept 2025 | Q3 | 81.1% | -40.0% | 506.2% | -9.8% | -42.35 | 1.84 | -1.6 |
| 30 Jun 2025 | Q2 | 79.9% | -57.3% | -1007.7% | -13.1% | 63.39 | 2.14 | -0.9 |
| 31 Mar 2025 | Q1 | 79.4% | -61.8% | -100.4% | -12.9% | 5.63 | 2.22 | -2.1 |
| 31 Dec 2024 | Q4 | 78.7% | -40.4% | -39.5% | -8.5% | 2.97 | 2.76 | -6.8 |
| 30 Sept 2024 | Q3 | 77.0% | -56.5% | -36.8% | -10.0% | 2.22 | 3.40 | -6.3 |
| 30 Jun 2024 | Q2 | 78.4% | -60.3% | -29.8% | -9.3% | 1.70 | 3.28 | -4.5 |
| 31 Mar 2024 | Q1 | 78.6% | -91.9% | 247.4% | -15.6% | -11.12 | 0.91 | -52.5 |
| 31 Dec 2023 | Q4 | 77.0% | -62.3% | -199.5% | -9.2% | 13.25 | 1.19 | -4.6 |